The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
The first trials enhancing orally-taken antiretroviral treatment with Solid Drug Nanoparticle technology have produced “incredibly promising” results.
The first ever study evaluating the decentralising of HIV care through antiretroviral treatment (ART) distribution centres shows low rates of patient loss in the city.